(Q40963145)

25 September 2017

1 reference

title

Leukotrienes as mediators of airway obstruction and inflammation in asthma (English)

1 reference

25 September 2017

Dahlén B

1

1 reference

25 September 2017

Dahlén SE

series ordinal

2

1 reference

25 September 2017

publication date

1 November 1995

1 reference

Clinical & Experimental Allergy

25 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 September 2017

volume

25 Suppl 2

1 reference

25 September 2017

page(s)

50-54

1 reference

Characteristics of formation and further metabolism of leukotrienes in the chopped human lung

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Peptide leukotrienes: current status of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: its repeatability, absence of a late-phase reaction, and the role of histamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Leukotrienes are potent constrictors of human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Urinary Excretion of Leukotriene E4and 11-dehydro-Thromboxane B2in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in Asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1995.TB00422.X

10.1111/J.1365-2222.1995.TB00422.X

21 January 2018

Identifiers

DOI

1 reference

release_2w24orijyfhtneyhongtfxbika

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2w24orijyfhtneyhongtfxbika

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference